Helminthic therapy and the liver
Autoimmune liver diseases, such as primary biliary cirrhosis, autoimmune hepatitis, and primary sclerosing cholangitis, were found to be modulated by active helminth infections in a case-controlled study involving 4,117 patients admitted to hospitals in Okinawa, Japan, between 1988 and 2006.[[1]
The authors hypothesized that immunomodulation by helminths may lower the incidence of autoimmune liver disease.
The scientific evidence[edit | edit source]
See
- Helminthic therapy and autoimmune diseases: Autoimmune hepatitis
- Helminthic therapy and cardiometabolic conditions: Non-alcoholic fatty liver disease
- Helminthic therapy and cancer: Liver cancer
- Helminthic therapy and infectious diseases: Helminths and hepatitis virus
See also
- 2025 Dec 1 Regulatory Role and Biomarker Potential of Gut Microbiota Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease to Hepatocellular Carcinoma -- Full text | PDF
- 2025 Dec Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease -- Full text | PDF
- 2025 Sep Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma
- 2025 Sep The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
- 2025 Aug 31 Insights Into Intestinal Flora in Metabolic Dysfunction-Associated Steatotic Liver Disease -- Full text
- 2025 Jul 15 Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease -- Full text | PDF
- 2025 Jul 1 Gut microbiota in patients with metabolic, dysfunction-associated steatotic liver disease
- 2024 Jun 20 Recombinant Schistosoma japonicum cystatin alleviates acute liver injury in mice by inhibiting endoplasmic reticulum stress, inflammation and hepatocyte apoptosis (Chinese)
- 2025 Jun 1 Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) -- Full text | PDF
- 2025 Apr 1 Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations -- Full text | PDF
- 2025 Mar 22 The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease -- Full text | PDF
- 2025 Feb Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease -- Full text | PDF
- 2024 Jul 27 Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics (Book chapter of Probiotics and Child Gastrointestinal Health)
- 2019 Jan Pathogens and autoimmune hepatitis
The anecdotal evidence[edit | edit source]
- Helminthic therapy and autoimmune diseases: Autoimmune hepatitis
- Helminthic therapy and autoimmune diseases: Primary sclerosing cholangitis
Autoimmune hepatitis[edit | edit source]
See Helminthic therapy and autoimmune diseases: Autoimmune hepatitis
Liver cancer[edit | edit source]
Liver fibrosis[edit | edit source]
- 2025 Dec Immunomodulatory and anti-fibrotic effects of Toxocara canis infection in a murine model of thioacetamide-induced chronic hepatic fibrosis
- 2024 Jun ATF3 is involved in rSjP40-mediated inhibition of HSCs activation in Schistosoma japonicum-infected mice
- 2024 Apr 10 Sja-let-7 suppresses the development of liver fibrosis via Schistosoma japonicum extracellular vesicles
- 2023 Nov 24 Sja-Let-7 Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in a Mouse Model via Col1α2
- 2020 Jul 9 Sja-miR-71a in Schistosome egg-derived extracellular vesicles suppresses liver fibrosis caused by schistosomiasis via targeting semaphorin 4D
- 2019 May rSJYB1 inhibits collagen type I protein expression in hepatic stellate cells via down-regulating activity of collagen α1 (I) promoter
- 2019 Feb Schistosoma japonicum soluble egg antigen inhibits TNF-α-induced IL-34 expression in hepatic stellate cells
- 2016 Dec 30 Soluble Egg Antigens of Schistosoma japonicum Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway
- 2016 Aug 4 Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
- 2016 Jul 28 Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
- 2014 Aug 21 Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression
- 2014 Mar Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism
- 2010 Apr Schistosoma mansoni: egg-induced downregulation of hepatic stellate cell activation and fibrogenesis
Mechanism of hepatic fibrosis by Schistosome
- 2024 Jul 30 Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs
- 2024 Jun Autophagy in hepatic progenitor cells modulates exosomal miRNAs to inhibit liver fibrosis in schistosomiasis
- 2023 May 30 Schistosome egg antigen stimulates the secretion of miR-33-carrying extracellular vesicles from macrophages to promote hepatic stellate cell activation and liver fibrosis in schistosomiasis
- 2022 Oct 28 Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
- 2022 Apr 27 A Novel miRNA From Egg-Derived Exosomes of Schistosoma japonicum Promotes Liver Fibrosis in Murine Schistosomiasis
- 2021 Feb 16 STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal Pathway
- 2020 Dec Expression of recombinant Schistosoma japonicum protein rSjE16 and its effects on LX-2 cells in vitro
- 2020 Mar 13 A MicroRNA Derived From Schistosoma japonicum Promotes Schistosomiasis Hepatic Fibrosis by Targeting Host Secreted Frizzled-Related Protein 1
- 2020 Mar A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III
- 2019 Oct 14 Soluble egg antigen of Schistosoma japonicum induces pyroptosis in hepatic stellate cells by modulating ROS production
- 2018 Jun Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells
- 2013 Feb 28 Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner
See also
- 2024 Nov 22 The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?
- 2021 Aug 5 MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6Clo Phenotype
Liver disease[edit | edit source]
Also see[edit | edit source]
- This thread in the Helminthic Therapy Support group.
- How a high fat ketogenic diet saved my life from primary sclerosing cholangitis.
Liver enzymes[edit | edit source]
NA can lower high liver enzymes
It’s also possible for NA to raise liver enzymes
Raised liver enzymes are most likely to be seen in the early stages of helminth colonisation.
Liver enzymes can test high for a variety of reasons
Liver enzymes can be raised by infections such as Epstein–Barr virus (EBV) and by other viruses, [4] and can also become elevated as a result of taking an immunosuppressant or certain supplements, or working out.
Primary sclerosing cholangitis[edit | edit source]
See Helminthic therapy and autoimmune diseases: Primary sclerosing cholangitis